Drug ID: | NPD4454 |
Drug Name: | Rafabegron |
Molecular Formula: | C21H23ClN2O4 |
Canonical SMILES: | C[C@H](Cc1c[nH]c2c1cccc2OCC(=O)O)NC[C@@H](c1cccc(c1)Cl)O |
Standard InCHI: | InChI=1S/C21H23ClN2O4/c1-13(23-11-18(25)14-4-2-5-16(22)9-14)8-15-10-24-21-17(15)6-3-7-19(21)28-12-20(26)27/h2-7,9-10,13,18,23-25H,8,11-12H2,1H3,(H,26,27)/t13-,18+/m1/s1 |
Standard InCHIKey: | FHEYFIGWYQJVDR-ACJLOTCBSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB016776 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 402.13 |
ALogP | -1.128 |
MLogP | 3 |
XLogP | 2.997 |
HDA | 5 |
HBD | 4 |
Rotatable Bonds | 13 |
TPSA | 94.58 |
RO5 Violation | 0 |